72 related articles for article (PubMed ID: 38435780)
21. A novel missense mutation in ADAMTS10 in Norwegian Elkhound primary glaucoma.
Ahonen SJ; Kaukonen M; Nussdorfer FD; Harman CD; Komáromy AM; Lohi H
PLoS One; 2014; 9(11):e111941. PubMed ID: 25372548
[TBL] [Abstract][Full Text] [Related]
22. ADAMTS-18: a metalloproteinase with multiple functions.
Wei J; Liu CJ; Li Z
Front Biosci (Landmark Ed); 2014 Jun; 19(8):1456-67. PubMed ID: 24896365
[TBL] [Abstract][Full Text] [Related]
23. The ADAMTS18 gene is responsible for autosomal recessive early onset severe retinal dystrophy.
Peluso I; Conte I; Testa F; Dharmalingam G; Pizzo M; Collin RW; Meola N; Barbato S; Mutarelli M; Ziviello C; Barbarulo AM; Nigro V; Melone MA; ; Simonelli F; Banfi S
Orphanet J Rare Dis; 2013 Jan; 8():16. PubMed ID: 23356391
[TBL] [Abstract][Full Text] [Related]
24. Tumor growth inhibitory effect of ADAMTS1 is accompanied by the inhibition of tumor angiogenesis.
Obika M; Ogawa H; Takahashi K; Li J; Hatipoglu OF; Cilek MZ; Miyoshi T; Inagaki J; Ohtsuki T; Kusachi S; Ninomiya Y; Hirohata S
Cancer Sci; 2012 Oct; 103(10):1889-97. PubMed ID: 22776012
[TBL] [Abstract][Full Text] [Related]
25. Microenvironmental regulation by fibrillin-1.
Sengle G; Tsutsui K; Keene DR; Tufa SF; Carlson EJ; Charbonneau NL; Ono RN; Sasaki T; Wirtz MK; Samples JR; Fessler LI; Fessler JH; Sekiguchi K; Hayflick SJ; Sakai LY
PLoS Genet; 2012 Jan; 8(1):e1002425. PubMed ID: 22242013
[TBL] [Abstract][Full Text] [Related]
26. Identification of ADAMTS18 as a gene mutated in Knobloch syndrome.
Aldahmesh MA; Khan AO; Mohamed JY; Alkuraya H; Ahmed H; Bobis S; Al-Mesfer S; Alkuraya FS
J Med Genet; 2011 Sep; 48(9):597-601. PubMed ID: 21862674
[TBL] [Abstract][Full Text] [Related]
27. Genetic and functional linkage between ADAMTS superfamily proteins and fibrillin-1: a novel mechanism influencing microfibril assembly and function.
Hubmacher D; Apte SS
Cell Mol Life Sci; 2011 Oct; 68(19):3137-48. PubMed ID: 21858451
[TBL] [Abstract][Full Text] [Related]
28. ADAMTS10 protein interacts with fibrillin-1 and promotes its deposition in extracellular matrix of cultured fibroblasts.
Kutz WE; Wang LW; Bader HL; Majors AK; Iwata K; Traboulsi EI; Sakai LY; Keene DR; Apte SS
J Biol Chem; 2011 May; 286(19):17156-67. PubMed ID: 21402694
[TBL] [Abstract][Full Text] [Related]
29. ADAMTS9 is a cell-autonomously acting, anti-angiogenic metalloprotease expressed by microvascular endothelial cells.
Koo BH; Coe DM; Dixon LJ; Somerville RP; Nelson CM; Wang LW; Young ME; Lindner DJ; Apte SS
Am J Pathol; 2010 Mar; 176(3):1494-504. PubMed ID: 20093484
[TBL] [Abstract][Full Text] [Related]
30. Homozygous mutations in ADAMTS10 and ADAMTS17 cause lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature.
Morales J; Al-Sharif L; Khalil DS; Shinwari JM; Bavi P; Al-Mahrouqi RA; Al-Rajhi A; Alkuraya FS; Meyer BF; Al Tassan N
Am J Hum Genet; 2009 Nov; 85(5):558-68. PubMed ID: 19836009
[TBL] [Abstract][Full Text] [Related]
31. Analysis of flavonoid-based pharmacophores that inhibit aggrecanases (ADAMTS-4 and ADAMTS-5) and matrix metalloproteinases through the use of topologically constrained peptide substrates.
Cudic M; Burstein GD; Fields GB; Lauer-Fields J
Chem Biol Drug Des; 2009 Nov; 74(5):473-82. PubMed ID: 19793184
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of ADAMTS-1, -4, and -5 in the trabecular meshwork.
Keller KE; Bradley JM; Acott TS
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5769-77. PubMed ID: 19553617
[TBL] [Abstract][Full Text] [Related]
33. Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations.
Bateman JF; Boot-Handford RP; Lamandé SR
Nat Rev Genet; 2009 Mar; 10(3):173-83. PubMed ID: 19204719
[TBL] [Abstract][Full Text] [Related]
34. Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor.
Basile DP; Fredrich K; Chelladurai B; Leonard EC; Parrish AR
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F928-36. PubMed ID: 18272597
[TBL] [Abstract][Full Text] [Related]
35. Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours.
Dunn JR; Reed JE; du Plessis DG; Shaw EJ; Reeves P; Gee AL; Warnke P; Walker C
Br J Cancer; 2006 Apr; 94(8):1186-93. PubMed ID: 16570050
[TBL] [Abstract][Full Text] [Related]
36. Ocular involvement in connective tissue disorders.
Young S
Curr Allergy Asthma Rep; 2005 Jul; 5(4):323-6. PubMed ID: 15967077
[TBL] [Abstract][Full Text] [Related]
37. The ADAMTS metalloproteinases.
Porter S; Clark IM; Kevorkian L; Edwards DR
Biochem J; 2005 Feb; 386(Pt 1):15-27. PubMed ID: 15554875
[TBL] [Abstract][Full Text] [Related]
38. Novel types of mutation responsible for the dermatosparactic type of Ehlers-Danlos syndrome (Type VIIC) and common polymorphisms in the ADAMTS2 gene.
Colige A; Nuytinck L; Hausser I; van Essen AJ; Thiry M; Herens C; Adès LC; Malfait F; Paepe AD; Franck P; Wolff G; Oosterwijk JC; Smitt JH; Lapière CM; Nusgens BV
J Invest Dermatol; 2004 Oct; 123(4):656-63. PubMed ID: 15373769
[TBL] [Abstract][Full Text] [Related]
39. ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome.
Dagoneau N; Benoist-Lasselin C; Huber C; Faivre L; Mégarbané A; Alswaid A; Dollfus H; Alembik Y; Munnich A; Legeai-Mallet L; Cormier-Daire V
Am J Hum Genet; 2004 Nov; 75(5):801-6. PubMed ID: 15368195
[TBL] [Abstract][Full Text] [Related]
40. Discovery and characterization of a novel, widely expressed metalloprotease, ADAMTS10, and its proteolytic activation.
Somerville RP; Jungers KA; Apte SS
J Biol Chem; 2004 Dec; 279(49):51208-17. PubMed ID: 15355968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
